Key result
Dendritic cells centrally regulate acute and chronic myocardial inflammation across diverse heart failure etiologies.
Why the study?
The cardiovascular-specific context involving dendritic cells in negotiating the biological response to myocardial injury is not well understood.
Dendritic cells are identified as central regulators of myocardial inflammation, presenting an emerging focus for diagnostic and therapeutic targets in heart failure.
May inform future immunomodulatory strategies in heart failure; leaves open precise dendritic cell targeting pending clinical validation.
The field of cardio-immunology has emerged from discoveries that define roles for innate and adaptive immune responses associated with myocardial inflammation and heart failure. Dendritic cells (DCs) comprise an important cellular compartment that contributes to systemic immune surveillance at the junction of innate and adaptive immunity. Once described as a singular immune subset, we now appreciate that DCs consist of a heterogeneous pool of subpopulations, each with distinct effector functions that can uniquely regulate the acute and chronic inflammatory response. Nevertheless, the cardiovascular-specific context involving DCs in negotiating the biological response to myocardial injury is not well understood. Herein, we review our current understanding of the role of DCs in cardiac inflammation and heart failure, including gaps in knowledge and clinical relevance.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2023) conducted a review in Heart Failure and Myocardial Inflammation. Dendritic cells was evaluated. Dendritic cells are heterogeneous immune subpopulations that act as central regulators of acute and chronic myocardial inflammation across various etiologies of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: